CAS: 175089-66-4

Applications 3,4-Dihydro-3-(4-hydroxyphenyl)-2H-1-benzopyran-4,7-diol-d6 is an isotopic analog of 3,4-Dihydro-3-(4-hydroxyphenyl)-2H-1-benzopyran-4,7-diol (175089-66-4), a metabolite of Daidzein. References Chang, Y., et al.: J. Nat. Prod., 58, 1892 (1995), Coldham, N., et al.: Xenobiotica, 32, 45 (2002), Fang, N., et al.: J. Agric. Food Chem. 50, 2700 (2002), Bowey, E., et al.: Food Chem. Toxicol., 41, 631 (2003),

rac-Tetrahydrodaidzein is a racemic compound, which is a mixture of two enantiomers. It is derived from the reduction of the isoflavone daidzein, primarily found in soybeans and other legumes. This compound exhibits interesting pharmacological properties due to its ability to interact with estrogen receptors, functioning as a modulator of estrogenic activity. Its mode of action involves binding to these receptors, potentially influencing various estrogen-mediated physiological processes. In research contexts, rac-Tetrahydrodaidzein is studied for its potential applications in fields such as oncology, osteoporosis, and cardiovascular health. It is of particular interest in cancer research due to its potential role in modulating pathways involved in cell proliferation and apoptosis. Additionally, its influence on bone density makes it a candidate for osteoporosis studies. The cardiovascular benefits are being explored in the context of its effects on lipid profiles and vascular function, making it a multifunctional compound with diverse implications for further scientific investigation.